Washington Electronic Business Solution #K9074

Washington State Health Care Authority Seeks Sole Source Pharmaceutical Pipeline Insights

This opportunity involves the Washington State Health Care Authority (HCA) seeking a sole source provider for pharmaceutical pipeline insights. - Government Buyer: - Washington State Health Care Authority (HCA) - OEMs and Vendors: - IPD Analytics (sole source vendor) - Products/Services Requested: - Pharmaceutical insights services - Detailed analysis of all therapies in development, including new and existing therapies seeking new indications - Focus on anticipated FDA approval review dates (PDUFA dates) - Assessment of clinical practice impact and economic implications for payors - Coverage spans a wide range of pharmaceutical categories (e.g., anesthetics, antihistamines, anti-infective agents, antineoplastic agents, cardiovascular drugs, hormones, vaccines, and more) - Unique or Notable Requirements: - Sole source procurement; only IPD Analytics is named - No specified quantity or part number - Submissions must be made electronically - No unique licensing or classification requirements specified

Description

The Washington State Health Care Authority (HCA) plans to award a sole source contract to IPD Analytics to provide detailed insights into the pharmaceutical pipeline for all therapies in development, including new therapies and existing therapies pursuing new indications. The insights will focus on anticipated FDA approval review dates (PDUFA dates), impact on clinical practice, and economic impact on payors. The procurement covers a wide range of pharmaceutical commodity codes. Responses are due by June 30, 2026, and submissions must be electronic.

View original listing